Canada Pension Plan Investment Board’s Sage Therapeutics SAGE Stock Holding History

Canada Pension Plan Investment Board’s Portfolio SAGE Stock Details SAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-63,300	Closed	-$1.19M	–	1434
2024 Q1	$1.19M	Hold	63,300	–	–	﹤0.01%	998
2023 Q4	$1.37M	Hold	63,300	–	–	﹤0.01%	900
2023 Q3	$1.3M	Hold	63,300	–	–	﹤0.01%	825
2023 Q2	$2.98M	Hold	63,300	–	–	﹤0.01%	661
2023 Q1	$2.66M	Buy	+63,300	New	+$2.72M	﹤0.01%	722
2021 Q1	–	Sell	-8,500	Closed	-$735K	–	1503
2020 Q4	$735K	Sell	8,500 -6,426	-43%	-$474K	﹤0.01%	1071
2020 Q3	$912K	Sell	14,926 -5,253	-26%	-$266K	﹤0.01%	754
2020 Q2	$839K	Buy	+20,179	New	+$732K	﹤0.01%	961
2017 Q4	–	Sell	-800	Closed	-$50K	–	1216
2017 Q3	$50K	Sell	800 -1,400	-64%	-$110K	﹤0.01%	1104
2017 Q2	$175K	Buy	+2,200	New	+$159K	﹤0.01%	1041

Other funds holding SAGE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Canada Pension Plan Investment Board's SAGE Position: Q2 2024 in Review

Canada Pension Plan Investment Board sold out of Sage Therapeutics (SAGE) in Q2 2024, closing a stake of 63,300 shares — an estimated $1.19M sold.

Canada Pension Plan Investment Board first reported a position in SAGE in Q2 2017 and held it in 10 quarters. The position peaked at $2.98M in Q2 2023. 195 funds tracked by Wall St. Rank hold SAGE as of Q2 2024.

Canada Pension Plan Investment Board reported no remaining Sage Therapeutics position as of Q2 2024 after selling out during the quarter.
Canada Pension Plan Investment Board sold 63,300 Sage Therapeutics shares in Q2 2024, an estimated $1.19M.
Canada Pension Plan Investment Board first reported a position in Sage Therapeutics in Q2 2017 and held it in 10 quarters.
Canada Pension Plan Investment Board's Sage Therapeutics position peaked at $2.98M in Q2 2023.
195 funds tracked by Wall St. Rank held Sage Therapeutics as of Q2 2024.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2024, filed 12 Aug 2024.